Theralink Technologies, Inc.
THER
Rank in Stocks
#33349
Theralink Technologies, Inc., headquartered in Golden, Colorado, is a... Theralink Technologies, Inc., headquartered in Golden, Colorado, is a commercial-stage enterprise specializing in precision medicine and the generation of crucial molecular data. The company is dedicated to advancing and bringing to market innovative cancer immunotherapy products. Utilizing its proprietary platform, which focuses on phosphoprotein and protein biomarkers, alongside its sophisticated laboratory-developed test (LDT) technology, Theralink addresses diverse aspects of oncology and pharmaceutical research. Through their specialized Theralink Reverse Phase Protein Array assays, they provide highly accurate oncology data. This information enables the biopharmaceutical industry and clinical oncologists to more precisely predict which patients will respond to, or be resistant to, both FDA-approved and investigational drug treatments. Ultimately, Theralink's diagnostic assays deliver vital, actionable insights that benefit physicians, patients, and biopharmaceutical companies operating within the field of cancer care. The company adopted its current name, Theralink Technologies, Inc., in September 2020, having previously operated as OncBioMune Pharmaceuticals, Inc.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$615.15K
Change (1 day)
0.00%
Change (1 year)
9,900.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Theralink Technologies, Inc. (THER)
Category
Healthcare
Operating Margin for Theralink Technologies, Inc. (THER)
Operating Margin as of November 2026 TTM: -1,479.80%
According to Theralink Technologies, Inc.'s latest financial reports, its current operating margin (TTM) is -1,479.80%. At the end of 2023 the company had an operating margin of -1,479.80%.
Operating Margin history for Theralink Technologies, Inc. from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1,479.80% | 0.00% |
| 2023 | -1,479.80% | -27.80% |
| 2022 | -2,049.64% | 86.19% |
| 2021 | -1,100.86% | -40.57% |
| 2020 | -1,852.24% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | -1,091,412.16% | 512.71% |
| 2014 | -178,127.56% | 11,846.69% |
| 2013 | -1,491.02% | 1,070.53% |
| 2012 | -127.38% | -67.03% |
| 2011 | -386.36% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.03% |
US
|
|
| -149.01% | -99.90% |
US
|
|
| 25.57% | -100.02% |
AU
|
|
| 31.23% | -100.02% |
BE
|
|
| 29.35% | -100.02% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Theralink Technologies, Inc.'s operating margin
What is Theralink Technologies, Inc.'s operating margin?
Theralink Technologies, Inc.'s operating margin is -1,479.80%, as of Nov 2026.
What was Theralink Technologies, Inc.'s operating margin in 2023?
In 2023, Theralink Technologies, Inc.'s operating margin was -1,479.80%, compared with -2,049.64% in 2022.
How has Theralink Technologies, Inc.'s operating margin changed since 2018?
From 2018 to 2023, Theralink Technologies, Inc.'s operating margin was highest in 2019 (0.00%) and lowest in 2022 (-2,049.64%).
How does Theralink Technologies, Inc.'s operating margin compare with similar companies?
Theralink Technologies, Inc.'s operating margin (-1,479.80%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.